ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE




Dr Shoaib Ahmed, Dr Sara Shafiq, Dr Tayyaba Mumtaz


ABackground: There is no agreement on finest screening technique for gestational diabetes mellitus. The purpose of the current study was consequently to examine the behaviour and practices of each obstetrical focus in north of Pakistan with regard to screening for pre-pregnancy DM in initial pregnancy and screening for gestational diabetes. Authors similarly expected to recognize penetration of the gestational DM screening system of Worldwide Association of DM in Pregnancy Research Set. Methods: The study was led from April 2018 to March 2019. The overview was dispersed to each obstetrics center in north of Pakistan by email, through telephone updates and individual contacts. Results: Out of 70 obstetrical centres, 72% reacted. All in all, 28% had an organized database on sum of females having GDM. Altogether things being equal, 82% of women were screened for pre-pregnancy DM in initial pregnancy and 57% were screened for GDM before 28 weeks. Screening before 24 weeks was largely dependent on random variables. Screening for GDM afterwards 28 weeks remained generally performed in 88% of centres. The average assessment of the ubiquity of MSD was 8 ± 6%. The maximum frequently used screening technique was the two-step methodology through the glucose challenge test and a 100-g oral glucose tolerance test, used through 57% of centres, including 25 centres using Carpenter and Coustan measures. The 75 g OGTT according to IADPSG measures remained used through 35% of subjects, nonetheless four subjects still used the OGTT before switching to full OGTT. Conclusion: The current study shows that in North part of Pakistan here is still very wide variety of screening methods for pre-pregnancy DM in initial pregnancy also GDM. Solitary 27% of the centres of interest have just implemented the IADPSG screening technique in a single step.

  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.